LifeSci Acquisition, a blank check company formed by LifeSci Capital targeting the healthcare industry, raised $60 million by offering 6 million units at $10 at a market cap of $73 million. The company originally planned to offer 5 million units. Each unit...read more
Six companies and five SPACs entered the public market raising about $2 billion. The week's deals mostly included uplistings, crosslistings, and micro-caps, with biotech Revolution Medicines (RVMD) soaring in the standout IPO of the...read more
LifeSci Acquisition, a blank check company targeting healthcare industry, announced terms for its IPO on Friday. The New York, NY-based company plans to raise $50 million by offering 5 million units at a price of $10 and would command a market value of $63...read more
US IPO Weekly Recap: GFL's billion-dollar IPO stumbles in shaky market
A billion-dollar IPO and two SPACs entered the market this past week, and four IPOs and five SPACs submitted initial filings. The ...read more
Healthcare SPAC LifeSci Acquisition prices $60 million IPO at $10
LifeSci Acquisition, a blank check company formed by LifeSci Capital targeting the healthcare industry, raised $60 million by offering 6 million units at $10 at a market cap of $73 million. The company originally planned to offer 5 million units. Each unit...read more
US IPO Weekly Recap: The year's busiest slow week?
Six companies and five SPACs entered the public market raising about $2 billion. The week's deals mostly included uplistings, crosslistings, and micro-caps, with biotech Revolution Medicines (RVMD) soaring in the standout IPO of the...read more
Healthcare SPAC LifeSci Acquisition sets terms for $50 million IPO
LifeSci Acquisition, a blank check company targeting healthcare industry, announced terms for its IPO on Friday. The New York, NY-based company plans to raise $50 million by offering 5 million units at a price of $10 and would command a market value of $63...read more